These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 33050704)

  • 1. Effectual Labeling of Natural Killer Cells with Upconverting Nanoparticles by Electroporation for In Vivo Tracking and Biodistribution Assessment.
    Park HS; Kim J; Cho MY; Cho YJ; Suh YD; Nam SH; Hong KS
    ACS Appl Mater Interfaces; 2020 Nov; 12(44):49362-49370. PubMed ID: 33050704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-Time Tracking of
    Uong TNT; Lee KH; Ahn SJ; Kim KW; Min JJ; Hyun H; Yoon MS
    Front Immunol; 2018; 9():825. PubMed ID: 29770131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging.
    Daldrup-Link HE; Meier R; Rudelius M; Piontek G; Piert M; Metz S; Settles M; Uherek C; Wels W; Schlegel J; Rummeny EJ
    Eur Radiol; 2005 Jan; 15(1):4-13. PubMed ID: 15616814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mRNA Transfection to Improve NK Cell Homing to Tumors.
    Levy ER; Carlsten M; Childs RW
    Methods Mol Biol; 2016; 1441():231-40. PubMed ID: 27177670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and (111)In-Oxine Labeling of Murine NK Cells for Assessment of Cell Trafficking in Orthotopic Lung Tumor Model.
    Malviya G; Nayak T; Gerdes C; Dierckx RA; Signore A; de Vries EF
    Mol Pharm; 2016 Apr; 13(4):1329-38. PubMed ID: 26962716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vivo Tracking of Cell Viability for Adoptive Natural Killer Cell-Based Immunotherapy by Ratiometric NIR-II Fluorescence Imaging.
    Liao N; Su L; Zheng Y; Zhao B; Wu M; Zhang D; Yang H; Liu X; Song J
    Angew Chem Int Ed Engl; 2021 Sep; 60(38):20888-20896. PubMed ID: 34268865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multifunctional nanoparticles for genetic engineering and bioimaging of natural killer (NK) cell therapeutics.
    Kim KS; Han JH; Park JH; Kim HK; Choi SH; Kim GR; Song H; An HJ; Han DK; Park W; Park KS
    Biomaterials; 2019 Nov; 221():119418. PubMed ID: 31419655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo pharmacokinetics, long-term biodistribution and toxicology study of functionalized upconversion nanoparticles in mice.
    Cheng L; Yang K; Shao M; Lu X; Liu Z
    Nanomedicine (Lond); 2011 Oct; 6(8):1327-40. PubMed ID: 21834646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards whole-body imaging at the single cell level using ultra-sensitive stem cell labeling with oligo-arginine modified upconversion nanoparticles.
    Wang C; Cheng L; Xu H; Liu Z
    Biomaterials; 2012 Jun; 33(19):4872-81. PubMed ID: 22483011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment.
    Lin M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2607-2618. PubMed ID: 28871458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Near-infrared emitting fluorescent nanocrystals-labeled natural killer cells as a platform technology for the optical imaging of immunotherapeutic cells-based cancer therapy.
    Lim YT; Cho MY; Noh YW; Chung JW; Chung BH
    Nanotechnology; 2009 Nov; 20(47):475102. PubMed ID: 19875875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive Tracking of Natural Killer Cells Using Gold Nanoparticles.
    Shamalov K; Meir R; Motiei M; Popovtzer R; Cohen CJ
    ACS Omega; 2021 Nov; 6(43):28507-28514. PubMed ID: 34746546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered nanoparticles to enhance natural killer cell activity towards onco-immunotherapy: a review.
    Phung CD; Tran TH; Kim JO
    Arch Pharm Res; 2020 Jan; 43(1):32-45. PubMed ID: 31993969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodistribution of biodegradable polymeric nano-carriers loaded with busulphan and designed for multimodal imaging.
    Asem H; Zhao Y; Ye F; Barrefelt Å; Abedi-Valugerdi M; El-Sayed R; El-Serafi I; Abu-Salah KM; Hamm J; Muhammed M; Hassan M
    J Nanobiotechnology; 2016 Dec; 14(1):82. PubMed ID: 27993139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogenic Natural Killer Cell Immunotherapy Combined with Irreversible Electroporation for Stage IV Hepatocellular Carcinoma: Survival Outcome.
    Alnaggar M; Lin M; Mesmar A; Liang S; Qaid A; Xu K; Chen J; Niu L; Yin Z
    Cell Physiol Biochem; 2018; 48(5):1882-1893. PubMed ID: 30092590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodistribution of sub-10 nm PEG-modified radioactive/upconversion nanoparticles.
    Cao T; Yang Y; Sun Y; Wu Y; Gao Y; Feng W; Li F
    Biomaterials; 2013 Sep; 34(29):7127-34. PubMed ID: 23796579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elemental bio-imaging of PEGylated NaYF
    Li Q; Wang Z; Chen Y; Zhang G
    Metallomics; 2017 Aug; 9(8):1150-1156. PubMed ID: 28745365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic effects of ex vivo-expanded natural killer cell-enriched lymphocytes (MYJ1633) against liver cancer.
    Choi JW; Lee ES; Kim SY; Park SI; Oh S; Kang JH; Ryu HA; Lee S
    BMC Cancer; 2019 Aug; 19(1):817. PubMed ID: 31426763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug target validation in primary human natural killer cells using CRISPR RNP.
    Rautela J; Surgenor E; Huntington ND
    J Leukoc Biol; 2020 Oct; 108(4):1397-1408. PubMed ID: 33463756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitoxantrone-loaded chitosan/hyaluronate polyelectrolyte nanoparticles decorated with amphiphilic PEG derivates for long-circulating effect.
    Wang J; Asghar S; Jin X; Chen Z; Huang L; Ping Q; Zong L; Xiao Y
    Colloids Surf B Biointerfaces; 2018 Nov; 171():468-477. PubMed ID: 30077147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.